A retrospective multicenter study to determine real-world effectiveness of ustekinumab in bio-naive patients with moderately to severely active Cohn's disease
Latest Information Update: 25 Jul 2022
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms JUSTify
Most Recent Events
- 25 Jul 2022 New trial record